Back to search

Article

Use of Metagenomic Microbial Plasma Cell-Free DNA Next-Generation Sequencing Assay in Outpatient Rheumatology Practice

2024-09-11

Abstract excerpt

<h4>Objectives</h4> To assess the utility of a metagenomic microbial plasma cell-free DNA next-generation sequencing assay (Karius Test TM ; KT) in the evaluation of patients in an outpatient rheumatology practice. <h4>Methods</h4> All patients with a KT ordered and obtained by a rheumatology provider in the outpatient setting from 1 January 2020 through 31 December 2022 were retrospectively identified. Demographi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a43a7e9f-3d87-5814-b0b8-2272665ee4c4
DOI
10.1101/2024.09.09.24313356
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Use of Metagenomic Microbial Plasma Cell-Free DNA Next-Generation Sequencing Assay in Outpatient Rheumatology PracticeDOI 10.1101/2024.09.09.24313356
Select a neighboring publication to make it the new centre.